Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleHot Topics

Patient Travel Concerns After Treatment with 177Lu-DOTATATE

Ayşe Tuba Kendi, Josh A. Mailman, Boris G. Naraev, David J. Mercer, James K. Underwood and Thorvardur R. Halfdanarson
Journal of Nuclear Medicine April 2020, 61 (4) 496-497; DOI: https://doi.org/10.2967/jnumed.120.243238
Ayşe Tuba Kendi
1Division of Nuclear Medicine, Department of Radiology, Mayo Clinic, Rochester, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josh A. Mailman
2NorCal CarciNET Community, Oakland, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Boris G. Naraev
3Banner M.D. Anderson Cancer Center, Gilbert, Arizona
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David J. Mercer
4Los Alamos National Laboratory, Los Alamos, New Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James K. Underwood
5Mayo Clinic Radiation Safety, Rochester, Minnesota; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thorvardur R. Halfdanarson
6Mayo Clinic Cancer Center, Rochester, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 61 no. 4 496-497
DOI 
https://doi.org/10.2967/jnumed.120.243238
PubMed 
32169915

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication February 5, 2020
  • Accepted for publication February 15, 2020
  • Published online April 1, 2020.

Article Versions

  • previous version (March 13, 2020 - 14:12).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2020 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

Statistics from Altmetric.com

Cited By...

  • 6 Citations
  • 5 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • High Interobserver Agreement for the Standardized Reporting System SSTR-RADS 1.0 on Somatostatin Receptor PET/CT
    Rudolf A. Werner, Thorsten Derlin, Steven P. Rowe, Lena Bundschuh, Gabriel T. Sheikh, Martin G. Pomper, Sebastian Schulz, Takahiro Higuchi, Andreas K. Buck, Frank M. Bengel, Ralph A. Bundschuh, Constantin Lapa
    Journal of Nuclear Medicine 2021 62 4
  • Best Patient Care Practices for Administering PSMA-Targeted Radiopharmaceutical Therapy
    Jeremie Calais, Michael J. Morris, Ayse Tuba Kendi, Arash Rezazadeh Kalebasty, Ronald Tutrone, Michael J. Anderson, Oliver Sartor
    Journal of Nuclear Medicine 2024 65 11
  • How green are radiopharmaceutical sciences?
    Verena Pichler, Matthias Manfred Herth, Verena Hugenberg, Peter J.H. Scott, Sarah Spreckelmeyer, Sophie Stotz, Giancarlo Pascali
    Nuclear Medicine and Biology 2025 144-145
  • Lutetium-177: Production and Radiopharmaceuticals
    Ayfer Asiye Akit
    Nuclear Medicine Seminars 2023 9 1
  • The Environmental Impact of Medical Imaging Agents and the Roadmap to Sustainable Medical Imaging
    Verena Pichler, Ricardo P. Martinho, Lisanne Temming, Tim Segers, Frederik R. Wurm, Olga Koshkina
    Advanced Science 2025 12 9

Article usage

Article usage: March 2020 to April 2025

AbstractFullPdf
Mar 20203048
Apr 202081238292
May 2020020489
Jun 2020010428
Jul 202004827
Aug 202009617
Sep 2020062031
Oct 2020026420
Nov 2020019719
Dec 202001588
Jan 20210459
Feb 202104617
Mar 202106433
Apr 202107626
May 20210448
Jun 202103711
Jul 202104126
Aug 202103321
Sep 202103541
Oct 202105142
Nov 202105531
Dec 202103318
Jan 202204621
Feb 202204016
Mar 202209441
Apr 202208012
May 202207824
Jun 202206025
Jul 202207519
Aug 202209329
Sep 202208024
Oct 202209640
Nov 202207419
Dec 2022024922
Jan 202308122
Feb 202308225
Mar 202307420
Apr 202308218
May 202307521
Jun 202308727
Jul 2023010214
Aug 2023010631
Sep 202307433
Oct 202307114
Nov 202307513
Dec 202309821
Jan 202409913
Feb 202409613
Mar 202409422
Apr 2024012422
May 2024010817
Jun 202407519
Jul 202406522
Aug 202406224
Sep 202407318
Oct 2024011724
Nov 2024015721
Dec 202409317
Jan 202509022
Feb 2025014317
Mar 2025010035
Apr 2025012133
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 61 (4)
Journal of Nuclear Medicine
Vol. 61, Issue 4
April 1, 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Patient Travel Concerns After Treatment with 177Lu-DOTATATE
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Patient Travel Concerns After Treatment with 177Lu-DOTATATE
Ayşe Tuba Kendi, Josh A. Mailman, Boris G. Naraev, David J. Mercer, James K. Underwood, Thorvardur R. Halfdanarson
Journal of Nuclear Medicine Apr 2020, 61 (4) 496-497; DOI: 10.2967/jnumed.120.243238

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Patient Travel Concerns After Treatment with 177Lu-DOTATATE
Ayşe Tuba Kendi, Josh A. Mailman, Boris G. Naraev, David J. Mercer, James K. Underwood, Thorvardur R. Halfdanarson
Journal of Nuclear Medicine Apr 2020, 61 (4) 496-497; DOI: 10.2967/jnumed.120.243238
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • Erratum
  • PubMed
  • Google Scholar

Cited By...

  • Best Patient Care Practices for Administering PSMA-Targeted Radiopharmaceutical Therapy
  • High Interobserver Agreement for the Standardized Reporting System SSTR-RADS 1.0 on Somatostatin Receptor PET/CT
  • Google Scholar

More in this TOC Section

  • RECIP 1.0: A Roadmap for Clinical Implementation
  • Diagnostic Radiopharmaceutical Trial Design: Is It Time to Change Nomenclature?
  • From Stabilization to Depletion: Molecular Imaging to Measure Therapeutic Response in ATTR-CA
Show more Hot Topics

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire